Nanopublications

@prefix this: <http://purl.org/np/RAySK-31NxhJAtKuFF_ytCHfpLYrFRXPWh6IRW_TwfwBY> .
@prefix sub: <http://purl.org/np/RAySK-31NxhJAtKuFF_ytCHfpLYrFRXPWh6IRW_TwfwBY#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix dct: <http://purl.org/dc/terms/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix orcid: <https://orcid.org/> .
@prefix nt: <https://w3id.org/np/o/ntemplate/> .
@prefix schema: <https://schema.org/> .
@prefix nkg: <https://w3id.org/neurodkg/> .
@prefix npx: <http://purl.org/nanopub/x/> .

sub:Head {
  this: np:hasAssertion sub:assertion ;
    np:hasProvenance sub:provenance ;
    np:hasPublicationInfo sub:pubinfo ;
    a np:Nanopublication .
}

sub:assertion {
  <http://purl.obolibrary.org/obo/DOID_1826> schema:possibleTreatment sub:medtherapy .
  sub:medtherapy prov:wasDerivedFrom sub:quote ;
    schema:drug <http://identifiers.org/drugbank/DB00949> ;
    schema:targetPopulation sub:targetpop ;
    nkg:indicationType nkg:SymptomaticReliefIndication .
  sub:quote prov:value "Felbamate oral suspension is recommended for use only in those patients who respond inadequately to alternative treatments and whose epilepsy is so severe that a substantial risk of aplastic anemia and/or liver failure is deemed acceptable in light of the benefits conferred by its use" ;
    prov:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2e325d79-d0a4-4af7-b09b-96ee5a5b2a37> .
}

sub:provenance {
sub:assertion prov:wasAttributedTo orcid:0000-0003-4665-7473 .
}

sub:pubinfo {
  sub:sig npx:hasAlgorithm "RSA" ;
    npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCC0CnI6yMUipkXh7RB8b/9rRnO8+qDR+pJVf//jGV0r2nd7JcvWFkhPN/eLja/pUw/+nvTE24rhKqK/jWxppJLoka+bk57wrYw43DrSbzQWoJc3ImWe3d08jSYt3mh3uOLWKciogBaonJUBohJsqhTmOULevIPONTZOMzeOJTWwQIDAQAB" ;
    npx:hasSignature "Faw6TOn8LOES/hlXXOPeRS7wPrrQjJf8wI2fOqyMon3C0KZai6JugAqvKyMBfgsaIgZ2BkQ+MJfNDqssJIDy+5EOMyGdasPBCP9Mp2Kwdnq3O2Nt0NfDvPv5GUiwJyw5/IDNrcqefpYD1JzgmRLxmc8GaW4s74r55J82tqXcMgw=" ;
    npx:hasSignatureTarget this: .
  this: dct:created "2021-04-04T21:34:28.183+02:00"^^xsd:dateTime ;
    dct:creator orcid:0000-0003-4665-7473 ;
    nt:wasCreatedFromProvenanceTemplate <http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM> ;
    nt:wasCreatedFromPubinfoTemplate <http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM> ;
    nt:wasCreatedFromTemplate <http://purl.org/np/RA64ptuigOfVGfIhpdwWeJnssaHV9jTQCnAm6Pvgrvmos> .
}